Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival
References (58)
- et al.
Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Anal Biochem
(1987) - et al.
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Anal Biochem
(1983) - et al.
β-transforming growth factor is stored in human blood platelets as a latent high molecular weight complex
Biochem Biophys Res Commun
(1986) - et al.
Transforming growth factor beta 1 in ductal carcinoma in situ and invasive carcinomas of the breast
Eur J Cancer
(1992) Stimulatory effects of transforming growth factor-beta and epidermal growth factor on epidermal cell outgrowth from porcine skin explant cultures
J Invest Dermatol
(1988)- et al.
Cancer statistics
Cancer J Clin
(1989) - et al.
Update on pancreatic cancer
Ca-Cancer J Clin
(1981) - et al.
Chemotherapy in pancreatic cancer
Br Med J
(1980) Current radiotherapeutic approaches to pancreatic cancer
Cancer
(1981)- et al.
A randomized controlled trial of adjuvant immuno-therapy (murine monoclonal antibody 494/32) in resectable pancreatic cancer
Cancer
(1991)
Treatment with an LHRH analogue in patients with advanced pancreatic cancer
Acta Chir Scand
(1990)
Treatment of duct carcinoma of the pancreas with the LH-RH-analogue buserelin
Pancreas
(1992)
Cancer of the pancreas. 50 years of surgery
Cancer
(1987)
Pancreas
Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increase in the levels of epidermal growth factor and transforming growth factor alpha
J Clin Invest
(1992)
Production of transforming growth factor alpha in human pancreatic cancer cells: evidence for a superagonistic autocrine cycle
Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness
Anticancer Res
(1993)
Growth inhibition of human pancreatic carcinoma cells by transforming growth factor beta-1
Growth Factors
(1993)
Synthesis and expression of transforming growth factor-beta 1, beta2, and beta3 in the endocrine and exocrine pancreas
Diabetes
(1993)
Transforming growth factor-β (TGF-β1) inhibits pancreatic acinar cell growth
Am J Physiol
(1992)
TNM Klassifikation maligner Tumoren
(1987)
Immunohistochemical localization of TGF-β1, TGF-β2, and TGF-β3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development
J Cell Biol
(1991)
Immunohistochemical staining for transforming growth factor beta 1 associates with disease progression in human breast cancer
Cancer Res
(1992)
Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization
J Clin Invest
(1988)
Pancreatic islet-acinar cell interaction: amylase messenger RNA levels are determined by insulin
Science
(1981)
Human transforming growth factor-β complementary sequence and expression in normal and transformed cells
Nature (Lond)
(1985)
Differential regulation of expression of three transforming growth factor-β species in human breast cancer cell lines by estradiol
Cancer Res
(1990)
Cloning and characterization of the abundant cytoplasmic 7S RNA from mouse cells
Nucleic Acids Res
(1982)
Nonparametric statistics for behavioral sciences
(1956)
Cited by (523)
Epithelial to Mesenchymal Transition
2022, Comprehensive PharmacologyTGF-β Signaling in Liver, Pancreas, and Gastrointestinal Diseases and Cancer
2021, GastroenterologyA Decade Later: Revisiting the TGFβ Family's Role in Diabetes
2021, Trends in Endocrinology and MetabolismTargeting all transforming growth factor-b isoforms with an Fc chimeric receptor impairs tumor growth and angiogenesis of oral squamous cell cancer
2020, Journal of Biological ChemistryCitation Excerpt :Thus, our approach to combine two receptors in a single Fc chimeric protein assures the same distributions of both receptors and increases the probability of trapping, leading to more effective therapy. TGF-β2 is overexpressed in various cancer types, including glioma (12) and pancreatic cancer (42), and its expression is also correlated with tumor progression. Several studies have reported attempts to target TGF-β2 in tumor tissues.
TGF-β signaling in health, disease, and therapeutics
2024, Signal Transduction and Targeted Therapy
View full text
Copyright © 1993 Published by Elsevier Inc.